E ʻimi i ka ʻili ʻili keʻokeʻo maikaʻi loa a ʻike ʻoe i nā inoa like ʻekolu: glutathione, vitamina C (ascorbic acid) a me tranexamic acid (TXA). Hōʻike pinepine nā kauka iā lākou ma ke ʻano he 'brightening shots', akā hana lākou ma nā ala like ʻole, hāʻawi ʻia ma nā ʻano like ʻole a lawe i nā pae hōʻike like ʻole. No laila ʻo wai ka mea e hoʻomālamalama maikaʻi i ka ʻili? ʻO ka pane ʻoiaʻiʻo e pili ana i ka pilikia pigment e mālama ʻia.
Ma kēia 'atikala, 'o ia ho'i, 'o ia ho'i ke 'ano o ke ahiahi a me ka mae ana o ka pua'a e like me ka melasma, nā kiko o ka lā a i 'ole nā hō'ailona post-inflammatory. ʻAʻole ia manaʻo e hoʻololi i ke kala ʻili maoli o ke kanaka, a ʻaʻole hiki i kekahi o kēia mau meaʻai ke hana mau loa. Ma lalo ʻoe e ʻike ai i kahi papaʻaina hoʻohālikelike ʻaoʻao, kahi ʻaoʻao pōkole o kēlā me kēia mea hoʻohui, kahi alakaʻi hoʻoholo e pili ana i ka ʻili a me nā kumu palekana a me nā kumu hoʻoponopono e ʻike pono ai nā keʻena lapaʻau a me nā mea hoʻolaha.
Glutathione vs Vitamin C vs Tranexamic Acid: Papa Hoʻohālikelike
Kumukumu
Glutathione (GSH)
Vitamin C (ʻakika ascorbic)
Tranexamic acid (TXA)
Mekani nui
Antioxidant tripeptide; Kāohi i ka tyrosinase pololei a me ka ʻole a hoʻololi i ka hana melanin mai ka eumelanin ʻeleʻele i ka phaeomelanin māmā.
Antioxidant; Kāohi i ka tyrosinase ma ka launa pū ʻana me ke keleawe ma ka wahi hana o ka enzyme, e hōʻemi ana i ka hoʻokumu ʻana o ka melanin.
Plasmin inhibitor; hoʻopau i ke ala plasminogen-plasmin e hoʻopili ai i ka ʻike UV a me nā ʻili ʻili i ka hoʻoulu ʻana i ka melanocyte.
Pehea e hoʻohana ʻia ai
ʻO nā capsule waha a i ʻole nā lozenges, nā ʻaila topical; Ua kaulana nā drips IV akā ʻaʻohe inoa; i kekahi manawa hoʻohui ʻia i ka cocktails mesotherapy intradermal
Nā serum kumuhana; intradermal mesotherapy a i ʻole microneedling no ka puaʻa; ʻO nā infusions IV kiʻekiʻe he kaʻawale, hoʻohana pūnaewele
Intradermal microinjection a i ʻole mesotherapy i loko o ka lesion, microneedling, topical, a me ka waha (kaukau)
Ua kūpono loa i
ʻO ka dullness maʻamau a me ke kākoʻo antioxidant, ma ke ʻano he mea hoʻohui
ʻO ka ʻeleʻele, ka pōʻino kiʻi a me ka pigment epidermal māmā; he hoa pili ma TXA
ʻO ka melasma a me ka paʻakikī, hormone- a i ʻole UV-driven facial pigment
ʻO ka maikaʻi o ka hōʻike
Hōʻike nā RCT waha liʻiliʻi a me ke kumuhana i nā hōʻemi haʻahaʻa melanin-index; hoʻokahi wale nō haʻawina IV i hoʻopaʻa ʻia ma kahi placebo, ʻaʻole ia he mea nui
ʻO nā hoʻokolohua liʻiliʻi a me kahi 2024 meta-analysis e hōʻike ana i ka mesotherapy me ka vitamin C e hana like me TXA mesotherapy i ka melasma
ʻO ka ikaika loa o nā ʻekolu no ka melasma, ʻoiai ʻo ka hapa nui o nā haʻawina injection he liʻiliʻi a pōkole
Nā memo palekana koʻikoʻi
Hoʻohana ʻia ka IV i pili i ke akepaʻa, ka ʻili a me ka ʻili i nā ʻōlelo aʻoaʻo regulator; ʻaʻole i ʻae ʻia ka hoʻopaʻa ʻana IV no ka uila ʻili
Hiki i ka hoʻohana intradermal ke kuʻi a puhi paha; ʻO ka hoʻohana ʻana i ka IV kiʻekiʻe e lawe ana i nā pilikia ma ke kīpē a me ka hemahema G6PD
ʻulaʻula kūloko, ʻeha a me ka ʻeha; ʻO ka hoʻomaʻamaʻa maʻamau ka nānā ʻana no ka pilikia clotting ma mua o ka hoʻohana ʻōnaehana
Nā hui maʻamau
Hoʻohui ʻia i ka cocktails TXA + vitamin C
Hoʻopili ʻia me TXA, me ka glutathione a i ʻole
ʻO ke kumu kumu o ka hapa nui o nā cocktails melasma
ʻO Glutathione: He mea kaulana, akā he lahilahi ka hōʻike
ʻO Glutathione kahi antioxidant kūlohelohe i loaʻa i loko o kēlā me kēia cell. Hōʻike nā loiloi i kona hopena uila e hele mai ana mai ke kāohi pololei a me ka ʻole o ka tyrosinase a mai ka hoʻololi ʻana i ka melanin synthesis i ka puaʻa māmā (Sonthalia et al., 2016). I nā haʻawina hoʻomalu, akā, he haʻahaʻa ka hopena. Ua ʻike ʻia kahi hoʻāʻo ʻelua makapō ma 60 mau mea manawaleʻa Thai he 500 mg o ka glutathione waha i kēlā me kēia lā no ʻehā pule i hōʻemi ʻia nā helu melanin ma mua o kahi placebo ma ʻelua wale nō o ʻeono mau pūnaewele (Arjinpathana a me Asawanonda). Ua hōʻike pū ʻia kahi haʻawina haʻahaʻa o kahi lozenge buccal ma 30 mau wahine Filipino i ka hāʻule ʻana o ka melanin, akā ʻaʻohe hui placebo (Handog et al., 2016).
ʻOi aku ka nāwaliwali o nā hōʻike no ka intravenous glutathione. ʻO ka haʻawina IV i hoʻopaʻa ʻia i ka placebo wale nō i loaʻa ʻaʻohe ʻokoʻa koʻikoʻi mai ka paʻakai (37.5% vs 18.7% i hoʻomaikaʻi ʻia, p = 0.054), ua mae ka hoʻomaikaʻi ʻana i loko o ʻeono mahina, a ua loaʻa i kekahi mau mea i komo i nā hoʻāʻo ate a i ʻole anaphylaxis (Zubair et al., 2016). A 2024 systematic review concluded IV glutathione is contraindicated for skin lighting and that glutathione 'hiki ke hana hou aku ma ke ano he antioxidant in melasma' (Sarkar et al.). No ka poʻe hoʻomanawanui, e ʻike i kā mākou alakaʻi i ka hana ʻana o ka glutathione skin whitening injections.
ʻO ka Vitamin C: ʻO ka hoa Antioxidant
Hoʻopau ka ʻakika Ascorbic i nā radical manuahi i hana ʻia e ke kukui UV a pale i ka tyrosinase, ʻo ia ke kumu i hoʻohana lōʻihi ʻia ai no ke kiʻi ʻana a me ka hyperpigmentation (Telang, 2013). ʻO kona nāwaliwali nui ka hāʻawi ʻana: ʻaʻole paʻa ka huaora C a paʻakikī ke komo i loko o ka dermis i nā ʻano kūpono, e wehewehe ana i ka hoihoi i ka mesotherapy a me ka microneedling.
Ke hoʻokomo ʻia ka huaora C i loko o ka ʻili no ka melasma, paʻa iā ia iho. Ma 2024 meta-analysis o ʻelima mau haʻawina (127 mau maʻi) ʻaʻohe ʻokoʻa koʻikoʻi i ka hoʻomaikaʻi ʻana i ka MASI ma waena o TXA mesotherapy a me ka vitamin C mesotherapy a ua manaʻo ʻia he palekana ʻelua (Liao et al.). He liʻiliʻi nā haʻawina, no laila ʻoi aku ka maikaʻi o kēia heluhelu ʻana ma ke ʻano he 'hoʻohālikelike i loko o ka ʻikepili i kaupalena ʻia' ma mua o ka hōʻoia o ka like.
ʻO Tranexamic Acid: ʻO ka Melasma Specialist
Ua hoʻomohala ʻia ka waikawa Tranexamic ma ke ʻano he lāʻau lapaʻau e hōʻemi i ke koko. ʻO kāna kuleana i loko o ka puaʻa mai ka pale ʻana i ka hana plasmin, kahi ala i komo i ka hoʻōla melanocyte i hoʻoiho ʻia e UV. Ma ka noiʻi intradermal mua, ua loaʻa i nā wahine Korea he 85 i kēlā me kēia pule he 4 mg / mL microinjections i loko o nā lesion melasma no nā pule he 12; ua hāʻule ka mean score MASI mai 13.22 a i 7.57 me nā hopena liʻiliʻi liʻiliʻi (Lee et al., 2006). ʻAʻohe pūʻulu mana o kēlā haʻawina. Ua loaʻa i kahi hoʻokolohua ma hope o 60 nā mea maʻi he 35.72% MASI hoʻomaikaʻi me TXA microinjections a me 44.41% me TXA i hāʻawi ʻia e microneedling, me ka ʻole o nā hanana ʻino nui (Budamakuntla et al., 2013).
Ua uhi ʻia nā kikoʻī protocol, nā wā kau a me nā koho maʻi i kā mākou ʻatikala hoʻolaʻa ma tranexamic acid mesotherapy no ka melasma , no laila ʻaʻole mākou e hana hou iā lākou ma aneʻi.
ʻO wai ka mea maikaʻi? He alakaʻi hoʻoholo na ka ʻili
ʻAʻohe mea hoʻokahi ʻoi aku ka maikaʻi loa. ʻO ka koho kūpono ma hope o ka hōʻailona:
Melasma
ʻO TXA ka mea mua loa i hiki i ka poʻe dermatologists, hāʻawi ʻia i loko a i ʻole me microneedling, me ka pale ʻana i ka lā. ʻO ka mesotherapy ka Vitamin C kahi koho kūpono a i ʻole hoa, hāʻawi ʻia i nā hopena like i ka meta-analysis. ʻO Glutathione kahi mea hoʻohui koho, ʻaʻole kahi pane kū hoʻokahi.
ʻO ka ʻeleʻele a me ka leo like ʻole
No ka ʻili luhi, ʻulaʻula a i ʻole nā kiʻi i hōʻino ʻia me ka ʻole o kahi maʻi puaʻa i wehewehe ʻia, ʻo ke kākoʻo antioxidant ka mea nui. ʻO ka Vitamin C ke kumu kūpono, a hiki i ka glutathione ke hāʻawi i ka pono antioxidant. Pono e hoʻopili ʻia nā mea i manaʻo ʻia ma ke ʻano he 'ʻili hou, ʻoi aku ka maikaʻi o ka ʻili', ʻaʻole he ʻili māmā.
ʻO ka hyperpigmentation post-inflammatory (PIH)
ʻO nā māka i waiho ʻia ma hope o ka ʻāʻī a i ʻole ka huhū maʻamau e mae me ka manawa, ka pale ʻana i ka lā a me ka mālama maʻalahi. Inā hoʻohana ʻia nā injectables, kūpono nā protocols haʻahaʻa haʻahaʻa me ka huaora C a i ʻole TXA, no ka mea, hiki i ka hoʻomaʻamaʻa ʻana ke hoʻoulu i ka puaʻa hou. ʻO kā mākou hiʻohiʻona o ʻO nā mea hoʻonaninani ʻili no ka hyperpigmentation e wehewehe i nā ʻano puaʻa nui i nā kikoʻī.
Kākoʻo Antioxidant e pili ana i nā kaʻina hana ʻē aʻe
Ua koho pinepine ʻia ka Vitamin C a me ka glutathione i mea kākoʻo e pili ana i nā lasers a i ʻole nā peels. ʻAʻole lākou e hoʻololi i kahi hoʻolālā lapaʻau pigment-specific.
Nā Kumu Hoʻohui: No ke aha e hoʻohana ai nā kauka he nui i nā mea ʻekolu
Ma muli o ka hana ʻana o nā mea ʻekolu i nā ʻanuʻu like ʻole o ka hoʻokumu ʻana i ka puaʻa, hoʻohui pinepine nā ʻano hoʻonaninani hou i ka TXA, ka huaora C a me ka glutathione ma mua o ke koho ʻana i hoʻokahi. Kākoʻo ka ʻikepili lapaʻau i kēia loiloi, ma ka liʻiliʻi ma nā hoʻokolohua liʻiliʻi. I loko o kahi ho'āʻo makapō ʻelua, ʻāpana-maka o nā maʻi melasma 24, ua hoʻohaʻahaʻa ʻo TXA me ka ascorbic acid i nā helu MASI ma mua o TXA a me kahi placebo i nā pule 8 a me 12, ʻoiai ʻoi aku ka ʻike ʻana o ka ʻeha ma ka ʻaoʻao hui (Pazyar et al., 2022). Ma kahi hoʻāʻo hoʻokaʻawale ʻē aʻe o nā maʻi 30, kahi cocktail o TXA 4 mg/mL, vitamina C 3% a me glutathione 2% i hōʻemi ʻia ka mMASI ma mua o TXA a me ka huaora C wale nō, me nā helu like o ka ʻulaʻula, ka pehu a me ka ʻeha (Iraji et al., 2019).
ʻAʻole ʻo IV glutathione kahi lāʻau hoʻomaʻemaʻe ʻili i nā mākeke he nui. Ma kāna ʻōlelo aʻoaʻo 2019, ua ʻōlelo ka Philippine FDA ʻaʻole ia i ʻae i kekahi huahana injectable no ka hoʻomaʻamaʻa ʻana i ka ʻili, ua ʻae ʻia ka glutathione injectable wale nō ma ke ʻano he adjunct i ka cisplatin chemotherapy, a ua ʻōlelo ʻo ia i ka hopena o ka ate, ka puʻupaʻa a me nā ʻōnaehana nerve a me Stevens-Johnson syndrome.
Lawe ʻia ka huaora C IV i ka nui o kona mau pilikia ponoʻī. Ua hōʻike ʻia ka ʻōlelo aʻoaʻo e hiki ke hana ʻia nā inikia o ka huaora C i nā pōhaku kīkī a ua alakaʻi ʻia nā kumu nui i ka hemodialysis i ka poʻe me ka hemahema G6PD.
ʻAʻole hiki ke hoʻopilikia ʻia nā injections kūloko. E manaʻo i ka ʻulaʻula liʻiliʻi, ke kuʻi ʻana, ka pehu a i ʻole ka ʻeha. Pono ka ʻenehana sterile a me ka hohonu pololei.
ʻAʻole mau ka hopena. Hoʻi hou ka puaʻa inā hoʻomau ka ʻike ʻana o UV, nā hormones a i ʻole ka mumū. ʻO ka pale ʻana i ka lā ākea ākea he ʻāpana o kēlā me kēia protocol.
E ʻike i kāu mau lula kūloko. He ʻokoʻa ka hoʻopaʻa inoa ʻana o ka huahana a ʻo wai ka mea i hoʻokomo ʻia ma ka ʻāina. Pono e kuhikuhi ʻia ka lāʻau lapaʻau e nā kauka loea.
No na Halemai a me na Mea Hoolaha
ʻIke nā kauka i nā hopena ʻoi aku ka maikaʻi a me ka liʻiliʻi o nā hoʻopiʻi ke ʻike mua lākou i ke ʻano puaʻa, koho i nā protocols-based TXA no ka melasma a hōʻike pololei i ka glutathione ma ke ʻano he antioxidant adjunct ma mua o ka mea hoʻololi kala ʻili. Pono nā mea kūʻai aku e hōʻoia i ka hoʻopaʻa inoa ʻana a me ka hoʻopaʻa inoa ʻana o kēlā me kēia huahana i kūpono i kā lākou mākeke.
Hana ʻo AOMA i nā hoʻonā mesotherapy hoʻomālamalama, me ka TXA, ka huaora C a me nā ʻano hui pū, no ka lako waiwai a me OEM. Hiki iā ʻoe ke nānā i ka AOMA ʻili keʻokeʻo i hoʻopaʻa ʻia . Hoʻomaka ka MOQ mai 200 mau ʻāpana no nā ʻāpana a me nā kauoha OEM. Hoʻouna ʻia nā kauoha kūʻai i loko o 24 mau hola, a ʻo ka manawa alakaʻi OEM he 2-3 mau pule ma hope o ka hoʻopaʻa ʻia ʻana o ka hana noʻeau, ka ʻōlelo a me nā kikoʻī kikoʻī. Paʻa ʻo AOMA i nā palapala CE, ISO 13485, GMP a me FDA.
FAQ
He aha ka maikaʻi keʻokeʻo keʻokeʻo?
ʻAʻohe lanakila hoʻokahi. No ka melasma, loaʻa i ka waika tranexamic ka ʻikepili i kākoʻo nui ʻia. No ka ʻeleʻele maʻamau, ʻo ka huaora C kahi koho antioxidant noʻonoʻo. ʻO Glutathione ka mea hoʻohui nui. Pono ke kauka e ʻike i ka pilikia pigment ma mua o ke koho ʻana.
ʻOi aku ka maikaʻi o ka glutathione ma mua o ka vitamina C no ka hoʻomālamalama ʻana i ka ʻili?
ʻAʻole maopopo. Loaʻa iā lāua nā hōʻike haʻahaʻa a pōkole wale nō. Loaʻa i ka Vitamin C ka ʻikepili injection no ka melasma, ʻoiai ʻo IV glutathione ʻaʻole i lanakila i ka placebo i kāna hoʻokolokolo hoʻomalu wale ʻia.
Hiki ke hoʻopili pū ʻia ka waiuma tranexamic, ka huaʻa C a me ka glutathione?
ʻAe, he mea maʻamau ka cocktails hui ʻana, a ua ʻike ʻia nā hoʻāʻo liʻiliʻi ʻāpana-maka ʻo ka hoʻohui ʻana i ka huaora C, a laila glutathione, i ka TXA i hoʻomaikaʻi i nā helu melasma. Hiki ke hoʻonui ʻia ke kuni ʻana a i ʻole ke kuʻi ʻana me ka hui pū ʻana.
Ke hoʻololi mau nei nā injections keʻokeʻo i ka ʻili?
ʻAʻole. Hiki iā lākou ke hoʻopau i ka puaʻa keu a me ka leo, akā ʻaʻole lākou e hoʻololi i ka waihoʻoluʻu ʻili maoli, a mae nā hopena me ka pale ʻole a mālama ʻia.
He palekana anei ka IV glutathione no ka hoʻomaʻemaʻe ʻili?
Ua aʻo aku nā mea hoʻoponopono e like me ka Philippine FDA, a me ka loiloi ʻōnaehana 2024 i manaʻo ʻia ʻo IV glutathione contraindicated no ka hoʻomālamalama ʻana o ka ʻili ma muli o ka nele o ka pono a me nā hopena ʻaoʻao.
Nā kuhikuhi
Lee JH, Park JG, Lim SH, et al. ʻO ka microinjection intradermal kūloko o ka waikawa tranexamic no ka mālama ʻana i ka melasma i nā maʻi maʻi ʻĀsia: kahi hoʻokolohua mua. ʻO Dermatol Surg . 2006;32(5):626–631. PMID: 16706756.
Budamakuntla L, Loganathan E, Suresh DH, et al. A randomized, open-label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling i nā maʻi me ka melasma. J Cutan Aeshet Surg . 2013;6(3):139–143. PMID: 24163529.
Liao X, Cheng F, Jiang Y. ʻO ka maikaʻi a me ka palekana o ka mesotherapy me ka tranexamic acid versus vitamin C i ka mālama ʻana i ka melasma: kahi meta-analysis a me ka loiloi ʻōnaehana. J Kosmet Dermatol . 2024;23(9):2785–2792. PMID: 38693699.
Pazyar N, Molavi SN, Hosseinpour P, et al. ʻO ka maikaʻi o ka intradermal injection o ka tranexamic acid a me ka ascorbic acid versus tranexamic acid a me ka placebo i ka mālama ʻana i ka melasma: kahi hoʻāʻo hoʻohālikelike hoʻohālikelike. Ola Sci Rep . 2022;5(2):e537. PMID: 35284654.
Iraji F, Nasimi M, Asilian A, et al. ʻO ka maikaʻi o ka mesotherapy me ka tranexamic acid a me ka ascorbic acid me ka ʻole o ka glutathione i ka mālama ʻana i ka melasma: kahi hoʻāʻo hoʻohālikelike hoʻohālikelike. J Kosmet Dermatol . 2019;18(5):1416–1421. PMID: 30735611.
Sonthalia S, Daulatabad D, Sarkar R. Glutathione ma ke ʻano he mea hoʻomaʻemaʻe ʻili: ʻoiaʻiʻo, nā moʻolelo, nā hōʻike a me nā hoʻopaʻapaʻa. Indian J Dermatol Venereol Leprol . 2016;82(3):262–272. PMID: 27088927.
Sarkar R, Yadav V, Yadav T, et al. ʻO Glutathione ma ke ʻano he mea hoʻomālamalama ʻili a me ka melasma: kahi loiloi ʻōnaehana. Int J Dermatol . 2025;64(6):992–1004 (ka pūnaewele 2024). PMID: 39444151.
ʻO Arjinpathana N, Asawanonda P. Glutathione ma keʻano he mea hoʻomaʻemaʻe waha: kahi haʻawina i hoʻopaʻaʻia, pālua-makapō, placebo-controlled. J Lapaau Dermatolog . 2012;23(2):97–102. PMID: 20524875.
Handog EB, Datuin MS, Singzon IA. ʻO kahi hōʻailona wehe, hoʻāʻo lima hoʻokahi o ka palekana a me ka pono o kahi hoʻomākaukau hou o ka glutathione ma ke ʻano he mea hoʻomālamalama ʻili i nā wahine Filipino. Int J Dermatol . 2016;55(2):153–157. PMID: 26148180.
Zubair S, Hafeez S, Mujtaba G. ʻO ka maikaʻi o ka glutathione intravenous vs. placebo no ka hoʻomālamalama ʻana i ka ʻili. J Pak Assoc Dermatol . 2016;26(3):177. https://jpad.com.pk/index.php/jpad/article/view/18
Telang PS. ʻO ka Vitamin C i ka dermatology. Indian Dermatol Online J . 2013;4(2):143–146. PMID: 23741676.
ʻAi a me nā lāʻau lapaʻau Philippines. FDA Advisory No. 2019-182: Hoʻohana palekana ʻole i ka glutathione ma ke ʻano he mea uila uila. 2019. https://www.fda.gov.ph/fda-advisory-no-2019-182-unsafe-use-of-glutathione-as-skin-lightening-agent/
No ka hoʻonaʻauao wale nō kēia ʻatikala a ʻaʻole ia he ʻōlelo aʻoaʻo olakino. Pono e loiloi ʻia a hoʻokō ʻia nā lāʻau hoʻomaʻamaʻa injectable e nā loea kūpono e like me nā lula kūloko.
ʻo Dr. Emily Carter (MD, Fellow of the American Academy of Dermatology) he kauka lapaʻau hoʻomaʻemaʻe i hōʻoia ʻia e ka papa ma New York City me ka ʻoi aku o 9 mau makahiki o ka ʻike kūikawā i ka hoʻopiha wai hyaluronic, ka mālama ʻana i ka maʻi ʻeha, a me ka liʻiliʻi o ka invasive o ka helehelena. Ua ʻike nui ʻia ʻo ia no kona akamai i nā lāʻau lapaʻau injectable holomua e hoʻomaʻamaʻa maikaʻi i nā ʻili ʻili, hoʻoikaika i ka hoʻōla ʻana o ka ʻili, a hoʻihoʻi hou i ka maʻalahi ma o ka hoʻoponopono ʻana i ka ʻili a me nā ʻenehana hoʻoikaika ʻili.
